Navigation Links
LDL particle measurement by NMR recognized by ADA, ACC
Date:3/28/2008

Raleigh, NC, March 28, 2008 - The American Diabetes Association (ADA) and the American College of Cardiology (ACC) issued a consensus statement today that states the measurement of LDL particle number by nuclear magnetic resonance (NMR) is one of the more accurate ways to evaluate cardiometabolic risk (CMR). The study, published in the April issue of Diabetes Care, reinforces that LDL cholesterol may not be the best way to quantify a patients risk for cardiovascular disease (CVD).

Cardiometabolic Risk (CMR) is associated with Type 2 Diabetes and CVD obesity, insulin resistance, hyperglycemia and hypertension are risk factors that often cluster together. ApoB and LDL particle concentration appear to be more closely associated with these markers of CMR than LDL cholesterol or non-HDL cholesterol. Subsequently, lipoprotein abnormalities are commonly found in patients with CMR. According to the consensus statement, ApoB and LDL particle number by NMR appear to be more discriminating measures of the adequacy of LDL lowering therapies than are traditional LDL and HDL cholesterol measures.

"Several studies have shown that LDL cholesterol (LDL-C) poorly characterizes lipid abnormalities in patients with cardiometabolic risk," says Robert S. Rosenson, MD, Director of Lipoprotein Disorders and Clinical Atherosclerosis Research, University of Michigan School of Medicine and presenter at the consensus panel meeting. "Additionally, LDL-P concentrations, compared to LDL-C and non HDL-C, have been shown to be stronger predictors of cardiovascular risk."

The NMR LipoProfile test, developed by LipoScience, Inc., is the only test that quantifies LDL particle number (LDL-P) using Nuclear Magnetic Resonance. LDL particle information is used by clinicians to monitor the effect of lipid altering interventions, such as statins, in the management of a patients cardiovascular health by lowering LDL particle number (LDL-P).

Studies show that low co
'/>"/>

Contact: Maura Siefring
msiefring@dorland.com
267-765-3974
Dorland Global Public Relations
Source:Eurekalert

1

GOOD

Page: 1 2

Related biology news :

1. Novel 3-D cell culture model shows selective tumor uptake of nanoparticles
2. Carnegie Mellon scientist uses mass spectrometer to weigh virus particle, von Willebrand factor
3. New nanoparticle vaccine is more effective but less expensive
4. Nanoparticle exposures happen, says expert
5. Worldwide atmospheric measurements will determine the role of atmospheric fine particles
6. MIT: Remote-control nanoparticles deliver drugs directly into tumors
7. MIT sculpts 3-D particles with light
8. Technique controls nanoparticle size, makes large numbers
9. Tiny dust particles from Asian deserts common over western United States
10. Particle accelerator may reveal shape of alternate dimensions
11. Mesothelin engineered on virus-like particles provides treatment clues for pancreatic cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...n.Researchers at Yale University have developed sy...immune response to HIV and HIV-infected cells, as ...published online in the Journal of the American C...approaches for these diseases. , The molecules ...V" (ARM-H) and "antibody-recruiting molecule targe...
(Date:11/4/2009)...Although scientists are reluctant to officially en...dence continues to grow about its protective effec... Cancer Prevention Research , a journal of the Ame...sts some reduction in oral cancer. , Vassiliki ... the Department of Thoracic/Head and Neck Medical ...
(Date:11/4/2009)...corridors in the cities of Long Beach and Riversid...preventable childhood asthma, and the true impact ... has likely been underestimated, according to rese...USC). , The study, which appears in an online e... estimated that nine percent of all childhood asth...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2USC study finds big air pollution impacts on local communities 2Beginning Swim Classes Too Advanced for Many Beginners 3B Swim Instructor Conference Slated 50151 1Beginning Swim Classes Too Advanced for Many Beginners 3B Swim Instructor Conference Slated 50151 2Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 1Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 2Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 3Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 4Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 5JustGetTested com Offers Fast Confidential HIV Testing to Mark National HIV Testing Day 50147 1JustGetTested com Offers Fast Confidential HIV Testing to Mark National HIV Testing Day 50147 2
...chers at Yale School of Medicine have found eviden... stimulates the higher brain functions of spatial ...sts that we may learn best on an empty stomach. , ...e Neuroscience by investigators at Yale and other ...lin, produced in the stomach and previously associ...
...ists have found that growth hormone, a substance t...ain, according to an article published in this wee...s. , The researchers -- from three institutions –?...ippocampus, a structure deep inside the brain that...ists also found that more growth hormone is produc...
...eriments with mice, researchers have found that el...ch for the development of pain-sensing neurons kno...." Such pain is abnormal pain that outlasts the in...ervous system changes. The animals rendered defici... response to discomfort caused by heat and cold an...
Other Biology News:Learning and memory stimulated by gut hormone 2Growth hormone is made in the brain, report scientists 2Master genetic switch found for chronic pain 2
(Date:11/6/2009)...ewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:...today announced updated results from a Phase II st...rcomas metastatic to the lung in a poster presenta... Society Meeting held in Miami Beach, Florida, fro...titled "A Phase II Study of Intravenous REOLYSIN (...
(Date:11/5/2009)...e hybrid . . . , Fuel economy ratings for the ...the www.fueleconomy.gov web site, which Oak Ridg...the U.S. Department of Energy and the U.S. Environ...les on the best fuel economy list are hybrid elect...hway). "This list proves that hybrids have gone ma...
(Date:11/5/2009)...v. 5 DSM Pharmaceutical Products t...liance with Galenix, Saint Jean D,Illac, France, w...nufacturing partner for Galenix commercial product...llaborate on business development opportunities co...ed on the strength of Galenix in drug product deve...
(Date:11/5/2009)...hursday, November 5, 2009 at 4:30 p.m. Eastern Tim...ire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (...ay reported unaudited financial results for the th...09 and reviewed the Company,s highlights for the t...ated results reflect the operations of OncoGenex T...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...Sales Reach $11.7 Million, PRINCETON, N.J., May 1..., a provider of advanced wound-care products,annou...ch 31, 2008. For the,quarter, sales were up 47 per...the newly acquired First Aid Division. The Company... due primarily to higher than expected,integration...
...Highlights: - IND for liquid formulation, NGX-19...inical development expected in second quarter of 2...n PHN expected in second half ...view for peripheral neuropathic pain, SAN MATEO, ...a biopharmaceutical company focused on developing ...
...Company secures global supply of top-quality custo...nd marketing executive, NEWBURGH, NY, USA and LIV...nics, developer of the i-LIMB Hand, the world,s fi...nic hand, today announced that it has,acquired the...of the unique,and lifelike prosthetic skin that To...
Other Biology Technology:Derma Sciences Reports First Quarter 2008 Results 2Derma Sciences Reports First Quarter 2008 Results 3Derma Sciences Reports First Quarter 2008 Results 4Derma Sciences Reports First Quarter 2008 Results 5NeurogesX Reports First Quarter 2008 Results 2NeurogesX Reports First Quarter 2008 Results 3NeurogesX Reports First Quarter 2008 Results 4NeurogesX Reports First Quarter 2008 Results 5NeurogesX Reports First Quarter 2008 Results 6NeurogesX Reports First Quarter 2008 Results 7Touch Bionics acquires LIVINGSKIN 2Touch Bionics acquires LIVINGSKIN 3
Mouse Anti-Human SNAPC5 Monoclonal Antibody, Unconjugated, Clone 6G10 from Abnova Corporation
...Mouse monoclonal antibody raised against a partial...28, 56 a.a. ~ 145 a.a) partial recombinant protein...QHEPFLDFLLGFSAGTEYMDLQNDLGQTALHLAAILGETSTVEKLYAAGA...8 Protein Accession Number: AAH15528 OMIM: ...
...The BD PhosFlow Perm/Wash Buffer I can be used in ...ified signaling proteins to permeabilize cells and...fer. Because saponin-mediated cell permeabilizatio... the cells in the presence of saponin during intra...
Mouse Anti-Human ACTN4 Monoclonal Antibody, Unconjugated, Clone 4D10 from Abnova Corporation
Biology Products: